Doxorubicin 2 mg/ml concentrat pentru soluţie perfuzabilă Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

doxorubicin 2 mg/ml concentrat pentru soluţie perfuzabilă

accord healthcare limited - doxorubicinum - concentrat pentru soluţie perfuzabilă - 2 mg/ml

Imatinib Actavis Uniunea Europeană - română - EMA (European Medicines Agency)

imatinib actavis

actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. , efectul de imatinib pe rezultatul de transplantul de măduvă osoasă nu a fost determinată. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. experiența cu imatinib la pacienții cu mds/mpd asociate cu genei fcdp-re-aranjamente este foarte limitat. nu există studii controlate care să demonstreze un beneficiu clinic sau a crescut de supraviețuire pentru aceste boli.

DOXORUBICINA ACCORD 2 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

doxorubicina accord 2 mg/ml

accord healthcare limited - marea britanie - doxorubicinum - conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite

DOXORUBICINA ACTAVIS 2 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

doxorubicina actavis 2 mg/ml

sindan - pharma s.r.l. - romania - doxorubicinum - conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite

DEXAMETAZONA ROMPHARM 4 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

dexametazona rompharm 4 mg/ml

rompharm company s.r.l. - romania - dexamethasonum - sol. inj. - 4mg/ml - corticosteroizi sistemici glucocorticoizi

DOXORUBICINA AGILA SPECIALTIES 2 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

doxorubicina agila specialties 2 mg/ml

agila specialties uk limited - doxorubicinum - pulb. pt.conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite

Dexamethason 4 mg/ml soluţie injectabilă Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dexamethason 4 mg/ml soluţie injectabilă

krka d.d., novo mesto - dexamethasonum - soluţie injectabilă - 4 mg/ml

Metotrexat-BP 10 mg/ml soluţie injectabilă Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

metotrexat-bp 10 mg/ml soluţie injectabilă

sc balkan pharmaceuticals srl - methotrexatum - soluţie injectabilă - 10 mg/ml

Metotrexat-BP 10 mg/ml soluţie injectabilă Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

metotrexat-bp 10 mg/ml soluţie injectabilă

sc balkan pharmaceuticals srl - methotrexatum - soluţie injectabilă - 10 mg/ml

DOXORUBICINA ACCORD 2 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

doxorubicina accord 2 mg/ml

accord healthcare b.v. - olanda - doxorubicinum - conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite